{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18(6)"],"submitter":["Lee S"],"funding":["Liver Research Institute, Seoul National University College of Medicine"],"pubmed_abstract":["<h4>Background/aims</h4><i>Helicobacter pylori</i> eradication can reduce the incidence of metachronous gastric neoplasm (MGN) after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). This study evaluated the risk of developing MGN after ESD for EGC based on age at <i>H. pylori</i> eradication.<h4>Methods</h4>Data of patients who underwent curative ESD for EGC with <i>H. pylori</i> infection between 2005 and 2018 were retrospectively analyzed. The patients were allocated to four groups according to age at <i>H. pylori</i> eradication: group 1 (<50 years), group 2 (50-59 years), group 3 (60-69 years), and group 4 (≥70 years).<h4>Results</h4>All patients were followed up for at least 5 years after ESD. The 5-year cumulative incidence of MGN was 2.1%, 7.0%, 8.7%, and 16.7%"],"journal":["Gut and liver"],"pagination":["992-1001"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11565006"],"repository":["biostudies-literature"],"pubmed_title":["Risk Assessment of Metachronous Gastric Neoplasm after Endoscopic Resection for Early Gastric Cancer According to Age at &lt;i&gt;Helicobacter pylori&lt;/i&gt; Eradication."],"pmcid":["PMC11565006"],"pubmed_authors":["Na YS","Kim SG","Lee S","Kim B","Kim J","Cho SJ","Chung H","Oh MJ","Lee JH"],"additional_accession":[]},"is_claimable":false,"name":"Risk Assessment of Metachronous Gastric Neoplasm after Endoscopic Resection for Early Gastric Cancer According to Age at &lt;i&gt;Helicobacter pylori&lt;/i&gt; Eradication.","description":"<h4>Background/aims</h4><i>Helicobacter pylori</i> eradication can reduce the incidence of metachronous gastric neoplasm (MGN) after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). This study evaluated the risk of developing MGN after ESD for EGC based on age at <i>H. pylori</i> eradication.<h4>Methods</h4>Data of patients who underwent curative ESD for EGC with <i>H. pylori</i> infection between 2005 and 2018 were retrospectively analyzed. The patients were allocated to four groups according to age at <i>H. pylori</i> eradication: group 1 (<50 years), group 2 (50-59 years), group 3 (60-69 years), and group 4 (≥70 years).<h4>Results</h4>All patients were followed up for at least 5 years after ESD. The 5-year cumulative incidence of MGN was 2.1%, 7.0%, 8.7%, and 16.7%","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2025-04-21T22:13:52.369Z","creation":"2025-04-05T18:40:02.659Z"},"accession":"S-EPMC11565006","cross_references":{"pubmed":["38509700"],"doi":["10.5009/gnl230383"]}}